7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 
      
    		                    
      cash flows from operating activities
    		                    
      net income
    		-32,733,000 -26,882,000 -21,529,000 -18,785,000 -25,524,000 -20,928,000 -24,061,000  -117,087,000 -24,598,000 -17,622,000 -55,723,000 -26,307,000 -33,873,000 -50,111,000 -50,386,000 -51,187,000 -40,926,000 -32,024,000 -18,318,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                    
      depreciation expense
    		286,000 277,000 283,000 304,000 294,000 322,000 325,000 13,710,167,000 331,000 343,000 331,000 364,000 277,000 274,000 257,000 209,000 166,000 85,000 32,000 6,000 
      stock-based compensation
    		3,285,000 3,190,000 3,294,000 3,216,000 3,357,000 3,332,000 3,198,000 790,512,106,000 2,040,000 2,222,000 1,675,000 4,103,000 4,470,000 4,141,000 5,329,000 4,955,000 5,086,000 4,549,000 3,594,000 2,013,000 
      change in fair value of warrant liability
    		292,000 273,000 -102,000 -83,000 -75,000 -195,000 337,000 -65,738,000             
      non-cash change in fair value of term loan
    		186,000 185,000 256,000 -732,000 403,000 -21,000 -247,000              
      debt issuance costs expensed under the fair value option
    		                    
      impairment of long-lived assets
    		   0    106,535,804,000             
      non-cash lease expense
    		312,000 308,000 339,000 301,000 297,000 294,000 325,000 11,820,407,000 305,000 303,000 300,000          
      other
    		28,000 241,000 -5,000 72,000 677,000 -26,000 27,000 741,325,000 194,000 259,000 128,000 290,000 229,000 193,000 194,000 295,000 -101,000    
      changes in operating assets and liabilities:
    		                    
      prepaid expenses and other assets
    		971,000 482,000 -1,052,000 819,000 -741,000 822,000 -693,000 60,108,080,000 3,499,000 909,000 -400,000 108,000 1,900,000 -191,000 271,000 -1,831,000 1,752,000 902,000 -4,184,000  
      accounts payable
    		-1,948,000 2,998,000 923,000 -1,504,000 -3,781,000 -1,615,000 3,980,000  -3,188,000 1,764,000 359,000 -4,587,000 -9,429,000 3,668,000 2,544,000 -1,506,000 13,618,000 510,000 1,872,000 -3,442,000 
      accrued expenses and other liabilities
    		5,008,000 732,000 -2,125,000 106,000 428,000 -2,377,000 422,000  -2,936,000 -1,074,000 -250,000 -1,570,000 205,000 -7,420,000 -538,000 5,363,000 -2,874,000 11,870,000 3,183,000  
      deferred revenue
    		0 -1,986,000 -2,302,000 -2,022,000 -1,788,000 -1,112,000 -3,411,000  -4,746,000 -2,395,000 -4,706,000          
      net cash from operating activities
    		-24,166,000 -20,182,000 -22,020,000 -18,308,000 -21,615,000 -21,504,000 -19,798,000  -17,949,000 -18,767,000 -20,185,000 14,277,000 -28,655,000 -33,208,000 -40,804,000 -40,258,000 -31,933,000 -22,816,000 -22,035,000 -19,848,000 
      capex
    		-108,000 -2,000 -378,000 2,000 -35,000 -201,000 -140,000  0 48,000 -3,900,000 -2,309,000 -2,020,000 -7,863,000 -8,427,000 -8,270,000 -3,502,000 -2,998,000 -534,000 -51,000 
      free cash flows
    		-24,274,000 -20,184,000 -22,398,000 -18,306,000 -21,650,000 -21,705,000 -19,938,000  -17,949,000 -18,719,000 -24,085,000 11,968,000 -30,675,000 -41,071,000 -49,231,000 -48,528,000 -35,435,000 -25,814,000 -22,569,000 -19,899,000 
      cash flows from investing activities
    		                    
      purchase of property, plant and equipment
    		-108,000 -2,000 -378,000 2,000 -35,000 -201,000 -140,000  0 48,000 -3,900,000 -2,309,000 -2,020,000 -7,863,000 -8,427,000 -8,270,000 -3,502,000 -2,998,000 -534,000  
      net cash from investing activities
    		-48,000 62,000 -371,000 13,000 -35,000 -201,000 -140,000  -3,490,000 48,000 -3,900,000 -2,370,000 -3,020,000 -8,113,000 -11,427,000 -8,520,000 -4,002,000 -8,498,000 -534,000 -6,051,000 
      cash flows from financing activities
    		                    
      proceeds from issuance of common stock and pre-funded warrants from underwritten public offering, net of underwriting discounts and sales commissions and other offering costs
    		-454,000   -360,000 6,659,000                
      prepayment of 2023 trinity term loan
    		                    
      proceeds from 2025 trinity term loan
    		                    
      debt issuance costs for term loan
    		   0 0 0 -18,000              
      payment of shelf registration costs
    		14,000 0 -47,000      0 0 -387,000 -39,000 -92,000 -76,000 -151,000      
      proceeds from common stock issuances under espp
    		84,000 0 75,000 0 63,000 0 26,000 68,185,000 18,000 0 50,000 0         
      proceeds from stock option exercises
    		                    
      net cash from financing activities
    		8,797,000 216,288,000 -52,000 -357,000 6,595,000 70,468,000 -22,000 13,639,211,456,000 140,634,000 377,000 -370,000 41,667,000 -258,000 10,930,000 -242,000 9,105,000    -1,482,000 
      net increase in cash, cash equivalents and restricted cash
    		-15,417,000   -18,652,000 -15,055,000   -20,375,000        -39,673,000     
      cash, cash equivalents and restricted cash at the beginning of the period
    		0 0 141,636,000 0 0 0 146,540,000 90,517,061,223,000 0 0 90,517,000 0 0 0 151,740,000 0     
      cash, cash equivalents and restricted cash at the end of the period
    		-15,417,000 196,168,000 119,193,000 -18,652,000 -15,055,000 48,763,000 126,580,000 14,653,923,602,000 119,195,000 -18,342,000 66,062,000 53,574,000 -31,933,000 -30,391,000 99,267,000 -39,673,000     
      cash and cash equivalents
    		-15,417,000 196,168,000 116,593,000 -18,652,000 -15,055,000 48,763,000 123,980,000 14,393,923,602,000 119,195,000 -18,342,000 63,425,000 53,574,000 -31,933,000 -30,391,000 96,630,000 -39,682,000     
      restricted cash
    		0 0 2,600,000 0 0 0 2,600,000 26,000,000,000 0 0 2,637,000 0 0 0 2,637,000 9,000     
      supplemental disclosure of cash flow information:
    		                    
      cash paid for interest
    		1,363,000 1,292,000 1,294,000 1,302,000 1,325,000 1,326,000 1,329,000 49,519,110,000 1,266,000 1,274,000 1,125,000 1,017,000 823,000 516,000 419,000 531,000    0 
      supplemental disclosure of noncash investing and financing activities:
    		                    
      proceeds allocated to success fee liability
    		                    
      property, plant and equipment in accounts payable and accrued expenses
    		   213,000   52,000    112,000 636,000 644,000 -1,791,000 4,513,000 1,624,000 3,350,000 2,207,000 1,101,000  
      offering costs not yet paid
    		-386,000 388,000 23,000 -314,000 -85,000   17,964,000             
      net decrease in cash, cash equivalents and restricted cash
    		  -22,443,000    -19,960,000   -18,342,000 -24,455,000 53,574,000 -31,933,000 -30,391,000 -52,473,000      
      research and development license expense
    		       34,997,750,000 0   0 0 0 1,250,000 3,000,000 1,250,000 0 5,500,000 3,000,000 
      issuance costs for pre-funded warrant liability
    		       0             
      non-cash loss on debt extinguishment
    		                    
      purchase of research and development license
    		           0 -1,000,000 -250,000 -3,000,000 -250,000 -500,000    
      repayment of svb term loan
    		                    
      proceeds from trinity tern loan
    		                    
      proceeds from issuance of common stock and pre-funded warrants from private placement, net of placement agent commissions and other offering costs
    		       -423,000             
      proceeds from issuance of common stock from private placement
    		                    
      reclassification of warrants to additional paid-in capital
    		                    
      allocation of proceeds to success fee liability
    		                    
      recognition of asset retirement obligation
    		                    
      issuance of warrants in connection with private placement
    		       0 0            
      payment of offering costs
    		                    
      research and development license not yet paid
    		                    
      proceeds from trinity term loan
    		                    
      proceeds from at-the-market offering, net of sales commissions and other offering costs
    		                    
      proceeds from public offering of common stock, net of sales commissions and other offering costs
    		                    
      proceeds from issuance of common stock to astellas, net of offering costs
    		                    
      proceeds from issuance of common stock from private placement, net of sales commissions
    		       0             
      right-of-use assets obtained in exchange for lease liabilities
    		                    
      proceeds from issuance of common stock, net of sales commissions
    		            0        
      purchase of research and development license not yet paid
    		             -250,000 1,250,000 2,750,000   5,500,000  
      due to related party
    		               0 0 0 -8,000  
      proceeds from term loan
    		               9,979,000     
      acquisition of property, plant and equipment funded by landlord
    		               0 0 -1,000 607,000  
      build-to-suit lease liability
    		               -357,000 357,000    
      deferred offering costs not yet paid
    		            -69,000 88,000 21,000 -63,000   128,000  
      espp contributions
    		             44,000 277,000      
      change in fair value of preferred stock tranche liability
    		                   0 
      proceeds from initial public offering, net of underwriting discounts and commission and other offering costs
    		                    
      proceeds from series a convertible preferred stock, net of issuance costs
    		                    
      proceeds from series b convertible preferred stock, net of issuance costs
    		                    
      proceeds from note payable to related party
    		                    
      repayment of note payable to related party
    		                    
      reclassification of preferred stock tranche liability
    		                    
      allocation of preferred stock tranche liability
    		                   0 
      conversion of series a and series b convertible preferred stock to common stock
    		                   0 
      build-to-suit lease
    		                    
      issuance costs for issuance of common stock in initial public offering not yet paid
    		                    
      series a convertible preferred stock issuance costs not yet paid
    		                    
      proceeds from issuances of series a convertible preferred stock
    		                    
      payment of series a convertible preferred stock issuance costs
    		                    
      net increase in cash and cash equivalents
    		                 -31,314,000 -22,569,000 -27,381,000 
      cash at the beginning of the period
    		                 0 251,253,000  
      cash at the end of the period
    		                 -31,314,000 228,684,000 -27,381,000 
      series a issuance costs not yet paid
    		                    
      purchase of research and development licenses
    		                    
      purchase of property and equipment
    		                   -51,000 
      proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commission and other offering costs
    		                   -1,308,000 
      proceeds from issuances of series a convertible preferred stock, net of issuance costs
    		                   -174,000 
      proceeds from issuance of series b convertible preferred stock, net of issuance costs
    		                   0 
      proceeds from notes payable to related party
    		                   0 
      repayment of notes payable to related party
    		                   0 
      property and equipment in accounts payable and accrued expenses
    		                    
      reclassification of preferred stock tranche liability upon share issuance
    		                   0 
      prepaid expenses
    		                    
      accrued expenses
    		                    
      issuance costs for issuances of common stock in initial public offering not yet paid
    		                    
      issuance costs for issuance of series a convertible preferred stock not yet paid
    		                    
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.